- Price
- $128.04
- Day
- +0.21%
- Mkt Cap
- $316.24B
- 52W Range
- $77.58 – $135.05
- Volume
- 8.35M
- Beta
- 0.21
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Merck beat Q2 earnings and sales estimates as strong oncology and newer products lift results, prompting the company to raise and narrow its 2026 sales outlook.
Read full article
Although the revenue and EPS for Merck (MRK) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read full article
Merck (MRK) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to earnings of $2.13 per share a year ago.
Read full article
Merck slashed its profit outlook for the year due to charges tied to its acquisition of cancer biotech company Terns Pharmaceuticals.
Read full article
Merck & Co., Inc. (MRK) Q2 2026 Earnings Call Transcript
Read full article
Stock futures are building on the strong start to August, today buzzing on Strait of Hormuz buzz
Read full article
The drugmaker posts a narrower-than-expected quarterly loss fueled by growth in its oncology segment.
Read full article
Merck reported higher-than-expected second-quarter sales on Tuesday and raised its full-year revenue forecast on the strength of its top-selling cancer treatment Keytruda.
Read full article
Total Revenue: $16.6 billion, an increase of 5% (4% excluding foreign exchange).KEYTRUDA Family Sales: Increased 4% to $8.4 billion, driven by uptake in earlier
Read full article
Merck beat second-quarter estimates and hiked its revenue outlook, as a slate of new products showed strong growth. But the pharmaceutical giant cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals.
Read full article
RAHWAY, N.J.--(BUSINESS WIRE)--Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results.
Read full article